Rxivist logo

Author: David Cooper

  • Most recently observed institution: Pfizer

Rankings

  • All-time downloads: 231,431 (rank: 183 )
  • Categories:
    • infectious diseases: 159,073 (rank: 86 (tie) )
    • microbiology: 72,358 (rank: 173 (tie) )

Downloads per author, site-wide

Preprints

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

infectious diseases more details view paper
  • Downloaded 65,971 times
  • Download rankings, all-time:
    • Site-wide: 75
    • In infectious diseases: 30
  • Year to date:
    • Site-wide: 180
  • Since beginning of last month:
    • Site-wide: 285

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

infectious diseases more details view paper
  • Downloaded 61,310 times
  • Download rankings, all-time:
    • Site-wide: 83
    • In infectious diseases: 33
  • Year to date:
    • Site-wide: 57
  • Since beginning of last month:
    • Site-wide: 71

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera

microbiology more details view paper
  • Downloaded 51,654 times
  • Download rankings, all-time:
    • Site-wide: 100
    • In microbiology: 8
  • Year to date:
    • Site-wide: 2
  • Since beginning of last month:
    • Site-wide: 42

Concurrent human antibody andTH1 type T-cell responses elicited by a COVID-19 RNA vaccine

infectious diseases more details view paper
  • Downloaded 21,731 times
  • Download rankings, all-time:
    • Site-wide: 301
    • In infectious diseases: 112
  • Year to date:
    • Site-wide: 413
  • Since beginning of last month:
    • Site-wide: 563

Neutralization of spike 69/70 deletion, E484K, and N501Y SARS-CoV-2 by BNT162b2 vaccine-elicited sera

microbiology more details view paper
  • Downloaded 20,704 times
  • Download rankings, all-time:
    • Site-wide: 316
    • In microbiology: 33
  • Year to date:
    • Site-wide: 24
  • Since beginning of last month:
    • Site-wide: 11

BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans

infectious diseases more details view paper
  • Downloaded 10,061 times
  • Download rankings, all-time:
    • Site-wide: 754
    • In infectious diseases: 228
  • Year to date:
    • Site-wide: 80
  • Since beginning of last month:
    • Site-wide: 108

PanLingua

Sign up for the Rxivist weekly newsletter! (Click here for more details.)


News